Treponema pallidum or Syphilis is a sexually transmitted disease. The disease has several consequences if left untreated and owing to this researchers have developed several advanced methods and equipment for the early detection of treponema pallidum. Some of them are nontreponemal tests, rapid plasma regain, and veneral disease research. The rapid increase in number of treponema pallidum cases across the globe is a primary factor boosting the global treponema pallidum tests market. As per a study, nearly 46 million people were infected with syphilis in 2015. Apart from this, there are many other factors influencing the growth of the global treponema pallidum tests market. Some of the factors responsible for the growth of the treponema pallidum tests market are listed below-
Get Sample Copy of this Report @
Treponema pallidum treatment is challenging for both patients and professionals. The foremost being its common symptoms with other illness. Due to this, there are several cases of misdiagnosis and ill-treatment for the disease. Thus there is an extreme need for treponema pallidum tests to overcome this challenge.
Apart from this, being a sexually transmitted disease there is a lot of taboo regarding treatment of the disease. Owing to this, several patients do not approach to doctors, and thus left untreated. All these factors pose a serious threat for the growth of the global treponema pallidum tests market
However governments across the globe have launched several advertisement and camps to increase awareness among people regarding prevention and treatment of the treponema pallidum. This is expected to offer a boost to the growth of the global treponema pallidum.
Read Comprehensive Overview of Report @
Treponema pallidum primarily transmit through sexual activities and high are the changes that a women pass this disease to fetus during pregnancy. Due to this, Center for Disease Control and Prevention (CDC) has made it mandatory for all pregnant women to get tested. This is a positive boost to the global treponema pallidum tests market.